Issues relative to generic pharmaceuticals and generic biologics; FY 2012 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); funding FDA Office of Generic Drugs; H.R. 1249, S. 23 - America Invents Act (2011).
S. 23, H.R. 1249 - America Invents Act (2011) - Issues relative to patent quality.
Duration: March 1, 2009
to
December 9, 2011
General Issues: Pharmacy , Copyright/Patent/Trademark
Spending: about $570,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2009: House of Representatives, U.S. Senate, Food & Drug Administration (FDA), Patent & Trademark Office (PTO), U.S. Senate,, Office of Management & Budget (OMB), Federal Trade Commission (FTC)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2011
The Russell Group, Inc. (formerly Russell & Barron, Inc.) terminated an engagement in which they represented Generic Pharmaceutical Association on Jan. 19, 2012.
Original Filing: 300443166.xml
Lobbying Issues
Issues relative to generic pharmaceuticals and generic biologics; FY 2012 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); funding FDA Office of Generic Drugs; H.R. 1249, S. 23 - America Invents Act (2011).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 23, H.R. 1249 - America Invents Act (2011) - Issues relative to patent quality.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
3rd Quarter, 2011
In Q3, Russell & Barron, Inc. lobbied for Generic Pharmaceutical Association , earning $50,000. The report was filed on Oct. 19, 2011.
Original Filing: 300421067.xml
Lobbying Issues
Issues relative to generic pharmaceuticals and generic biologics; FY 2011 and FY 2012 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); funding FDA Office of Generic Drugs; H.R. 1249, S. 23 - America Invents Act (2011).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 23, H.R. 1249 - America Invents Act (2011) - Issues relative to patent quality.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
2nd Quarter, 2011
In Q2, Russell & Barron, Inc. lobbied for Generic Pharmaceutical Association , earning $50,000. The report was filed on July 18, 2011.
Original Filing: 300393134.xml
Lobbying Issues
Issues relative to generic pharmaceuticals and generic biologics; FY 2011 and FY 2012 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); funding FDA Office of Generic Drugs; H.R. 1249, S. 23 - America Invents Act (2011).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 23, H.R. 1249 - America Invents Act (2011) - Issues relative to patent quality.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
1st Quarter, 2011
In Q1, Russell & Barron, Inc. lobbied for Generic Pharmaceutical Association , earning $40,000. The report was filed on April 12, 2011.
Original Filing: 300362518.xml
Lobbying Issues
Issues relative to generic pharmaceuticals and generic biologics; FY 2011 and FY 2012 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); funding FDA Office of Generic Drugs; H.R. 1249, S. 23 - America Invents Act (2011).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 23, H.R. 1249 - America Invents Act (2011) - Issues relative to patent quality.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
4th Quarter, 2010
In Q4, Russell & Barron, Inc. lobbied for Generic Pharmaceutical Association , earning $40,000. The report was filed on Jan. 18, 2011.
Original Filing: 300347186.xml
Lobbying Issues
Issues relative to generic pharmaceuticals and generic biologics; FY 2011 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); funding FDA Office of Generic Drugs; H.R. 1427, S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act (entire bill); S. 369 - Preserve Access to Affordable Generics Act (entire bill)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 515, H.R. 1260, Patent Reform Act of 2009 - Issues relative to patent quality
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
3rd Quarter, 2010
In Q3, Russell & Barron, Inc. lobbied for Generic Pharmaceutical Association , earning $40,000. The report was filed on Oct. 20, 2010.
Original Filing: 300328055.xml
Lobbying Issues
Issues relative to generic pharmaceuticals and generic biologics; FY 2011 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); H.R. 1427, S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act (entire bill); S. 369 - Preserve Access to Affordable Generics Act (entire bill)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 515, H.R. 1260, Patent Reform Act of 2009 - Issues relative to patent quality
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
2nd Quarter, 2010
In Q2, Russell & Barron, Inc. lobbied for Generic Pharmaceutical Association , earning $50,000. The report was filed on July 20, 2010.
Original Filing: 300297102.xml
Lobbying Issues
Issues relative to generic pharmaceuticals and generic biologics; FY 2011 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); H.R. 1427, S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act (entire bill); S. 369 - Preserve Access to Affordable Generics Act (entire bill)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 515, H.R. 1260, Patent Reform Act of 2009 - Issues relative to patent quality
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
1st Quarter, 2010
In Q1, Russell & Barron, Inc. lobbied for Generic Pharmaceutical Association , earning $50,000. The report was filed on April 20, 2010.
Original Filing: 300272780.xml
Lobbying Issues
Issues relative to generic pharmaceuticals and generic biologics; H.R. 2997, S. 1406 - 2010 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); H.R. 1427, S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act (entire bill); S. 369 - Preserve Access to Affordable Generics Act (entire bill)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 515, H.R. 1260, Patent Reform Act of 2009 - Issues relative to patent quality
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
4th Quarter, 2009
In Q4, Russell & Barron, Inc. lobbied for Generic Pharmaceutical Association , earning $60,000. The report was filed on Jan. 15, 2010.
Original Filing: 300240921.xml
Lobbying Issues
Issues relative to generic pharmaceuticals and generic biologics; H.R. 2997, S. 1406 - 2010 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); H.R. 1427, S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act (entire bill); S. 369 - Preserve Access to Affordable Generics Act (entire bill)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 515, H.R. 1260, Patent Reform Act of 2009 - Issues relative to patent quality
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
3rd Quarter, 2009
In Q3, Russell & Barron, Inc. (Lesher, Russell & Barron, Inc.) lobbied for Generic Pharmaceutical Association , earning $60,000. The report was filed on Oct. 20, 2009.
Original Filing: 300214580.xml
Lobbying Issues
Issues relative to generic pharmaceuticals and generic biologics; H.R. 2997, S. 1406 - 2010 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); H.R. 1427, S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act (entire bill); S. 369 - Preserve Access to Affordable Generics Act (entire bill)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 515, H.R. 1260, Patent Reform Act of 2009 - Issues relative to patent quality
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
2nd Quarter, 2009
In Q2, Russell & Barron, Inc. (Lesher, Russell & Barron, Inc.) lobbied for Generic Pharmaceutical Association , earning $60,000. The report was filed on July 17, 2009.
Original Filing: 300181765.xml
Lobbying Issues
Issues relative to generic pharmaceuticals and generic biologics;
H.R. 2997, S. 1406 - 2010 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services);
H.R. 1427, S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act (entire bill)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 515, H.R. 1260, Patent Reform Act of 2009 - Issues relative to patent quality
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
1st Quarter, 2009
In Q1, Lesher, Russell & Barron, Inc. lobbied for Generic Pharmaceutical Association , earning $20,000. The report was filed on April 20, 2009.
Original Filing: 300160055.xml
Lobbying Issues
Issues relative to generic pharmaceuticals and generic biologics
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 515, H.R. 1260, Patent Reform Act of 2009 - Issues relative to patent quality
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
1st Quarter, 2009
Lesher, Russell & Barron, Inc. filed a lobbying registration on April 12, 2009 to represent Generic Pharmaceutical Association, effective March 1, 2009.
Original Filing: 300147070.xml
Issue(s) they said they’d lobby about: Issues related to generic pharmaceuticals and generic biologics
S. 515, H.R. 1260, Patent Reform Act of 2009 (issues related to patent quality) .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...